These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19854223)

  • 41. Investigations of a prion infectivity assay to evaluate methods of decontamination.
    Fichet G; Comoy E; Dehen C; Challier L; Antloga K; Deslys JP; McDonnell G
    J Microbiol Methods; 2007 Sep; 70(3):511-8. PubMed ID: 17640752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prion organotypic slice culture assay--POSCA.
    Falsig J; Aguzzi A
    Nat Protoc; 2008; 3(4):555-62. PubMed ID: 18388937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimating prion adsorption capacity of soil by BioAssay of Subtracted Infectivity from Complex Solutions (BASICS).
    Wyckoff AC; Lockwood KL; Meyerett-Reid C; Michel BA; Bender H; VerCauteren KC; Zabel MD
    PLoS One; 2013; 8(3):e58630. PubMed ID: 23484043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prion removal capacity of plasma protein manufacturing processes: a data collection from PPTA member companies.
    Cai K; Gröner A; Dichtelmüller HO; Fabbrizzi F; Flechsig E; Gajardo R; von Hoegen I; Jorquera JI; Kempf C; Kreil TR; Lee DC; Moscardini M; Pölsler G; Roth NJ
    Transfusion; 2013 Sep; 53(9):1894-905. PubMed ID: 23252676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced detection of prion infectivity from blood by preanalytical enrichment with peptoid-conjugated beads.
    Hornemann S; Schwarz P; Rushing EJ; Connolly MD; Zuckermann RN; Yam AY; Aguzzi A
    PLoS One; 2019; 14(9):e0216013. PubMed ID: 31513666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein.
    Lee DC; Stenland CJ; Hartwell RC; Ford EK; Cai K; Miller JL; Gilligan KJ; Rubenstein R; Fournel M; Petteway SR
    J Virol Methods; 2000 Jan; 84(1):77-89. PubMed ID: 10644089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of PrP transgenic
    Thackray AM; Andréoletti O; Bujdoso R
    F1000Res; 2018; 7():595. PubMed ID: 29946445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assaying prions in cell culture: the standard scrapie cell assay (SSCA) and the scrapie cell assay in end point format (SCEPA).
    Mahal SP; Demczyk CA; Smith EW; Klohn PC; Weissmann C
    Methods Mol Biol; 2008; 459():49-68. PubMed ID: 18576147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A simple, versatile and sensitive cell-based assay for prions from various species.
    Arellano-Anaya ZE; Savistchenko J; Mathey J; Huor A; Lacroux C; Andréoletti O; Vilette D
    PLoS One; 2011; 6(5):e20563. PubMed ID: 21655184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The standard scrapie cell assay: development, utility and prospects.
    van der Merwe J; Aiken J; Westaway D; McKenzie D
    Viruses; 2015 Jan; 7(1):180-98. PubMed ID: 25602372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fast and ultrasensitive method for quantitating prion infectivity titre.
    Makarava N; Savtchenko R; Alexeeva I; Rohwer RG; Baskakov IV
    Nat Commun; 2012 Mar; 3():741. PubMed ID: 22415832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioassays and Inactivation of Prions.
    Giles K; Woerman AL; Berry DB; Prusiner SB
    Cold Spring Harb Perspect Biol; 2017 Aug; 9(8):. PubMed ID: 28246183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pyrosequencing-based barcodes for a dye-free multiplex bioassay.
    Chen Z; Fu X; Zhang X; Liu X; Zou B; Wu H; Song Q; Li J; Kajiyama T; Kambara H; Zhou G
    Chem Commun (Camb); 2012 Feb; 48(18):2445-7. PubMed ID: 22267084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are matrix effects the Achilles heel in the bioanalysis of biotherapeutics by ligand-binding assays?
    Wang Q; Ma M
    Bioanalysis; 2014 Apr; 6(8):1041-4. PubMed ID: 24830887
    [No Abstract]   [Full Text] [Related]  

  • 58. Alternatives to animal bioassays for prions.
    Beekes M; Wagenführ K
    Altern Lab Anim; 2013 Dec; 41(6):P72-6. PubMed ID: 24512235
    [No Abstract]   [Full Text] [Related]  

  • 59. The application of cytochemistry to the highly sensitive bioassay of polypeptide hormones.
    Chayen J; Bitensky L
    Pathol Res Pract; 1980 Dec; 170(1-3):39-49. PubMed ID: 18788151
    [No Abstract]   [Full Text] [Related]  

  • 60. A rapid one-step multiwell tray test for release of soluble mediators.
    Caspi RR
    J Immunol Methods; 1986 Oct; 93(1):141-4. PubMed ID: 3490517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.